Variants with large effects on blood lipids and the role of cholesterol and triglycerides in coronary disease

Nature Genetics

Volumn 48, Issue 6, 2016, Pages 634-639

  Helgadottir, Anna ^a,b   Gretarsdottir, Solveig ^a   Thorleifsson, Gudmar ^a   Hjartarson, Eirikur ^a   Sigurdsson, Asgeir ^a   Magnusdottir, Audur ^a   Jonasdottir, Aslaug ^a   Kristjansson, Helgi ^a   Sulem, Patrick ^a   Oddsson, Asmundur ^a   Sveinbjornsson, Gardar ^a   Steinthorsdottir, Valgerdur ^a   Rafnar, Thorunn ^a   Masson, Gisli ^a   Jonsdottir, Ingileif ^a,b,c   Olafsson, Isleifur ^c   Eyjolfsson, Gudmundur I ^d   Sigurdardottir, Olof ^e   Daneshpour, Maryam S ^f   Khalili, Davood ^g   Azizi, Fereidoun ^h   Swinkels, Dorine W ⁱ   Kiemeney, Lambertus ^j   Quyyumi, Arshed A ^k   Levey, Allan I ^k   Patel, Riyaz S ^k   Hayek, Salim S ^k   Gudmundsdottir, Ingibjorg J ^c   Thorgeirsson, Gudmundur ^b,c   Thorsteinsdottir, Unnur ^a,b   Gudbjartsson, Daniel F ^a,b   Holm, Hilma ^a,c   Stefansson, Kari ^a,b   more..

^a DECODE GENETICS   (Iceland)

^b UNIVERSITY OF ICELAND   (Iceland)

^c LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^d Laboratory in Mjodd   (Iceland)

^e Akureyri Hospital   (Iceland)

^f SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^g SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^h SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

ⁱ RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^j RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^k EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; ANGPTL3 PROTEIN; ANGPTL4 PROTEIN; APOA1 PROTEIN; APOB PROTEIN; APOC1 PROTEIN; APOC3 PROTEIN; CHOLESTEROL ESTER TRANSFER PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LDLR PROTEIN; LIPC PROTEIN; LIPG PROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LPL PROTEIN; MAP1A PROTEIN; NON HIGH DENSITY LIPOPROTEIN CHOLESTEROL; NR1H3 PROTEIN; PCSK9 PROTEIN; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PROTEIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; CHOLESTEROL; LIPID;

ALLELE; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FOLLOW UP; FREQUENCY; GENE FREQUENCY; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOME-WIDE ASSOCIATION STUDY; HUMAN; ICELANDER; LOSS OF FUNCTION MUTATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; GENETICS;

CHOLESTEROL; CORONARY ARTERY DISEASE; HUMANS; LIPIDS; TRIGLYCERIDES;

EID: 84965036429     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.3561     Document Type: Article

References (41)

1. Barter, P.J., et al. Effects of torcetrapib in patients at high risk for coronary events. N. Engl. J. Med. 357, 2109-2122 (2007
2. Schwartz, G.G., et al. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N. Engl. J. Med. 367, 2089-2099 (2012
3. HPS2-THRIVE Collaborative Group. Effects of extended-release niacin with laropiprant in high-risk patients. N. Engl. J. Med. 371, 203-212 (2014
4. Peloso, G.M., et al. Association of low-frequency and rare coding-sequence variants with blood lipids and coronary heart disease in 56,000 whites and blacks. Am. J. Hum. Genet. 94, 223-232 (2014
5. Lange, L.A., et al. Whole-exome sequencing identifies rare and low-frequency coding variants associated with LDL cholesterol. Am. J. Hum. Genet. 94, 233-245 (2014
6. Jørgensen, A.B., Frikke-Schmidt, R., Nordestgaard, B.G., & Tybjærg-Hansen, A. Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. N. Engl. J. Med. 371, 32-41 (2014
7. TG and HDL Working Group of the Exome Sequencing Project, National Heart, Lung, and Blood Institute. Loss-of-function mutations in APOC3, triglycerides, and coronary disease. N. Engl. J. Med. 371, 22-31 (2014
8. Do, R., et al. Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction. Nature 518, 102-106 (2015
9. Brown, M.S., & Goldstein, J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 232, 34-47 (1986
10. Holmes, M.V., et al. Mendelian randomization of blood lipids for coronary heart disease. Eur. Heart J. 36, 539-550 (2015
11. Do, R., et al. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat. Genet. 45, 1345-1352 (2013
12. Voight, B.F., et al. Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study. Lancet 380, 572-580 (2012
13. Varbo, A., et al. Remnant cholesterol as a causal risk factor for ischemic heart disease. J. Am. Coll. Cardiol. 61, 427-436 (2013
14. Kong, A., et al. Detection of sharing by descent, long-range phasing and haplotype imputation. Nat. Genet. 40, 1068-1075 (2008
15. Styrkarsdottir, U., et al. Nonsense mutation in the LGR4 gene is associated with several human diseases and other traits. Nature 497, 517-520 (2013
16. McLaren, W., et al. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 26, 2069-2070 (2010
17. Sveinbjornsson, G., et al. Weighting sequence variants based on their annotation increases power of whole-genome association studies. Nat. Genet. 48, 314-317 (2016
18. Sherry, S.T., et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res. 29, 308-311 (2001
19. Bowden, J., Davey Smith, G., & Burgess, S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int. J. Epidemiol. 44, 512-525 (2015
20. Gudnason, V., Sigurdsson, G., Nissen, H., & Humphries, S.E. Common founder mutation in the LDL receptor gene causing familial hypercholesterolaemia in the Icelandic population. Hum. Mutat. 10, 36-44 (1997
21. Brunham, L.R., & Hayden, M.R. Human genetics of HDL: insight into particle metabolism and function. Prog. Lipid Res. 58, 14-25 (2015
22. Whitfield, A.J., Barrett, P.H.R., van Bockxmeer, F.M., & Burnett, J.R. Lipid disorders and mutations in the APOB gene. Clin. Chem. 50, 1725-1732 (2004
23. Berbée, J.F.P., van Der Hoogt, C.C., Sundararaman, D., Havekes, L.M., & Rensen, P.C.N. Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL. J. Lipid Res. 46, 297-306 (2005
24. Tontonoz, P., & Mangelsdorf, D.J. Liver X receptor signaling pathways in cardiovascular disease. Mol. Endocrinol. 17, 985-993 (2003
25. Emerging Risk Factors Collaboration. Major lipids, apolipoproteins, and risk of vascular disease. J. Am. Med. Assoc. 302, 1993-2000 (2009
26. Würtz, P., et al. Lipoprotein subclass profiling reveals pleiotropy in the genetic variants of lipid risk factors for coronary heart disease: a note on Mendelian randomization studies. J. Am. Coll. Cardiol. 62, 1906-1908 (2013
27. Rohatgi, A., et al. HDL cholesterol efflux capacity and incident cardiovascular events. N. Engl. J. Med. 371, 2383-2393 (2014
28. Helgason, A., Nicholson, G., Stefánsson, K., & Donnelly, P. A reassessment of genetic diversity in Icelanders: strong evidence from multiple loci for relative homogeneity caused by genetic drift. Ann. Hum. Genet. 67, 281-297 (2003
29. Clarke, R., et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N. Engl. J. Med. 361, 2518-2528 (2009
30. Bennet, A.M., et al. Association of apolipoprotein E genotypes with lipid levels and coronary risk. J. Am. Med. Assoc. 298, 1300-1311 (2007
31. Friedewald, W.T., Levy, R.I., & Fredrickson, D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499-502 (1972
32. Joint International Society and Federation of Cardiology/World Health Organization Task Force on Standardization of Clinical Nomenclature. Nomenclature and criteria for diagnosis of ischemic heart disease. Circulation 59, 607-609 (1979
33. Scanlon, P.J., et al. ACC/AHA guidelines for coronary angiography: executive summary and recommendations. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Coronary Angiography) developed in collaboration. Circulation 99, 2345-2357 (1999
34. Wetzels, J.F.M., Kiemeney, L.A., Swinkels, D.W., Willems, H.L., & den Heijer, M. Age-and gender-specific reference values of estimated GFR in Caucasians: the Nijmegen Biomedical Study. Kidney Int. 72, 632-637 (2007
35. Azizi, F., et al. Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials 10, 5 (2009
36. Khalili, D., et al. The incidence of coronary heart disease and the population attributable fraction of its risk factors in Tehran: a 10-year population-based cohort study. PLoS One 9, e105804 (2014
37. Helgadottir, A., et al. A common variant on chromosome 9p21 affects the risk of myocardial infarction. Science 316, 1491-1493 (2007
38. Kutyavin, I.V., et al. A novel endonuclease IV post-PCR genotyping system. Nucleic Acids Res. 34, e128 (2006
39. Li, H., & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009
40. Kong, A., et al. Parental origin of sequence variants associated with complex diseases. Nature 462, 868-874 (2009
41. Steinthorsdottir, V., et al. Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes. Nat. Genet. 46, 294-298 (2014